141 related articles for article (PubMed ID: 31486618)
1. Elevated ferritin and soluble CD25 in critically ill patients are associated with parameters of (hyper) inflammation and lymphocyte cytotoxicity.
von Bahr Greenwood T; Palmkvist-Kaijser K; Chiang SC; Tesi B; Bryceson YT; Hjelmqvist H; Henter JI
Minerva Anestesiol; 2019 Dec; 85(12):1289-1298. PubMed ID: 31486618
[TBL] [Abstract][Full Text] [Related]
2. Hyperferritinemia in Critically Ill Patients.
Lachmann G; Knaak C; Vorderwülbecke G; La Rosée P; Balzer F; Schenk T; Schuster FS; Nyvlt P; Janka G; Brunkhorst FM; Keh D; Spies C
Crit Care Med; 2020 Apr; 48(4):459-465. PubMed ID: 32205591
[TBL] [Abstract][Full Text] [Related]
3. The Use of Ferritin to Identify Critically Ill Patients With Secondary Hemophagocytic Lymphohistiocytosis.
Grangé S; Buchonnet G; Besnier E; Artaud-Macari E; Beduneau G; Carpentier D; Dehay J; Girault C; Marchalot A; Guerrot D; Tamion F
Crit Care Med; 2016 Nov; 44(11):e1045-e1053. PubMed ID: 27441901
[TBL] [Abstract][Full Text] [Related]
4. Clinical and laboratory signs of haemophagocytic lymphohistiocytosis associated with pandemic influenza A (H1N1) infection in patients needing extracorporeal membrane oxygenation: A retrospective observational study.
von Bahr Greenwood T; Holzgraefe B; Chiang SCC; Wang Y; Tesi B; Bryceson YT; Henter JI
Eur J Anaesthesiol; 2021 Jul; 38(7):692-701. PubMed ID: 33186307
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic significance of NK cell activity and soluble CD25 level in serum from patients with secondary hemophagocytic lymphohistiocytosis].
Wang Z; Wang YN; Feng CC; Tian LP; Chen X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1154-7. PubMed ID: 18928616
[TBL] [Abstract][Full Text] [Related]
6. Hemophagocytic lymphohistiocytosis (HLH) in a 25-year-old presenting with multisystem organ failure.
Lane S; Andrist C; Nagarajan A
W V Med J; 2013; 109(6):22-3. PubMed ID: 24371860
[TBL] [Abstract][Full Text] [Related]
7. [Significance of soluble interleukin-2 receptor and NK cell activity in patients with hemophagocytic lymphohistiocytosis].
Wang LL; Hu YX; Chen WF; Xu J; Zhang W; Wu YJ; Tian T; Qiu HX; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):401-4. PubMed ID: 22541108
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*.
Rajasekaran S; Kruse K; Kovey K; Davis AT; Hassan NE; Ndika AN; Zuiderveen S; Birmingham J
Pediatr Crit Care Med; 2014 Jun; 15(5):401-8. PubMed ID: 24583503
[TBL] [Abstract][Full Text] [Related]
9. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.
Allen CE; Yu X; Kozinetz CA; McClain KL
Pediatr Blood Cancer; 2008 Jun; 50(6):1227-35. PubMed ID: 18085676
[TBL] [Abstract][Full Text] [Related]
10. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
[TBL] [Abstract][Full Text] [Related]
11. Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
Osman M; Faridi RM; Sligl W; Shabani-Rad MT; Dharmani-Khan P; Parker A; Kalra A; Tripathi MB; Storek J; Cohen Tervaert JW; Khan FM
Blood Adv; 2020 Oct; 4(20):5035-5039. PubMed ID: 33075136
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a protein biochip to detect serum IgG antibodies against IL-2 and soluble CD25 in hemophagocytic lymphohistiocytosis.
Liu Q; Liu SS; Li SG; Gao Y; Ye L; Johnson GOR; Song ZJ; Du WD
Clin Chim Acta; 2018 Dec; 487():256-263. PubMed ID: 30292629
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Serum HMGB-1 in Patients with Secondary Hemo-phagocytic Lymphohistiocytosis and Its Clinical Significance].
Wang DJ; Wang JJ; Song M; Gao X; Duan LM; Tian T; Qiu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):878-83. PubMed ID: 27342526
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
Knaak C; Nyvlt P; Schuster FS; Spies C; Heeren P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Crit Care; 2020 May; 24(1):244. PubMed ID: 32448380
[TBL] [Abstract][Full Text] [Related]
15. Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patients.
Knaak C; Schuster FS; Nyvlt P; Heeren P; Spies C; Schenk T; La Rosée P; Janka G; Brunkhorst FM; Lachmann G
PLoS One; 2021; 16(7):e0254345. PubMed ID: 34252125
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Debaugnies F; Mahadeb B; Nagant C; Meuleman N; De Bels D; Wolff F; Gottignies P; Salaroli A; Borde P; Voué M; Corazza F
J Clin Immunol; 2021 Apr; 41(3):658-665. PubMed ID: 33417087
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis.
Otrock ZK; Hock KG; Riley SB; de Witte T; Eby CS; Scott MG
Ann Hematol; 2017 Oct; 96(10):1667-1672. PubMed ID: 28762079
[TBL] [Abstract][Full Text] [Related]
18. Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect.
Carvelli J; Piperoglou C; Farnarier C; Vely F; Mazodier K; Audonnet S; Nitschke P; Bole-Feysot C; Boucekine M; Cambon A; Hamidou M; Harle JR; de Saint Basile G; Kaplanski G
Blood; 2020 Jul; 136(5):542-552. PubMed ID: 32356861
[TBL] [Abstract][Full Text] [Related]
19. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
20. Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
Knaak C; Schuster FS; Spies C; Vorderwülbecke G; Nyvlt P; Schenk T; Balzer F; La Rosée P; Janka G; Brunkhorst FM; Keh D; Lachmann G
Shock; 2020 Jun; 53(6):701-709. PubMed ID: 31626037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
